Prospector
Profile
07.1162
|
| |
| Angiotech Pharmaceuticals, Inc. |
NAICS |
339100 |
| 1618 Station Street
Vancouver, British Columbia V6A 1B6 Canada |
Description |
Medical Equipment Mfg. |
| (604) 221-6933 |
Employees |
0 |
| http://www.angiotech.com/ |
Revenue |
(mil) |
315.0800 |
| |
Income |
(mil) |
-4.6900 |
| |
Assets |
(mil) |
1205.8700 |
| |
Liability |
(mil) |
650.5000 |
| |
(for the year ended 2006-12-31) |
| |
|
Category:
Low Rating
|
| |
|
Event:
Standard & Poor's Ratings Services lowered Angiotech Pharmaceuticals, Inc.'s senior subordinated debt rating to 'CCC' from 'B-'. The outlook is negative. "This two-notch downgrade reflects Angiotech's sharply deteriorating credit metrics caused by the declining royalty revenue stream from drug-eluting stents and the lack of visibility regarding cash flow generation," S&P credit analyst Maude Tremblay said.
|
| |
|
Intellectual Property:
The Company has patent protected technology on many of products and potential product candidates. Its portfolio of intellectual property developed, licensed or acquired to date, includes over 240 issued U.S. patents and 240 pending U.S. patent applications. The Company has obtained licenses from third parties with respect to intellectual property used in connection with its technology. Certain of its key technology includes trade secrets and know-how that may not be protected by patents. [SEC Filing 40-F 03-30-07]
|
| |
|
Description:
The Company develops medical products that combine devices with drugs to make them more effective with fewer side effects.
|
| |
|
Officers:
William Hunter (Pres. & CEO); David M. Hill (SVP-Gov't. & Community Relations); David D. McMasters (SVP-Legal & Gen. Counsel); Jeffrey P. Walker (SVP-Research & Dev't.); Tom Bailey (CFO); Gary Ingenito (Chief Clinical & Regulatory Affairs Officer); Rui Avelar (Chief Medical Officer)
|
| |
|
Auditor:
PricewaterhouseCoopers LLP
|
| |
|
Securities:
Common Stock Symbol ANP.TO; TSX;
84,983,735 common shares outstanding as of Dec. 31, 2006.
|
| |
| |
| |
| return to main page |
